The Cooper Companies, Inc.

(NASDAQ Global Select)
Back to all articles
Slightly Bullish +25

Is Cooper Companies Stock Underperforming the Dow?

AI-generated analysis

🏒 The Cooper Companies (COO), a California-based manufacturer, specializes in contact lens wearers, fertility products, and medical devices with a market cap of $13.9 billion.

πŸ’° As a large-cap stock valued over $10 billion, COO holds significant influence within the medical instruments and supplies industry.

πŸ“‰ COO shares are currently down 20.9% from their 52-week high of $89.83 reached on Dec. 05, 2025.

πŸ“Š The company has experienced a downward trajectory, declining 12.3% over the past three months while lagging behind the Dow Jones Industrials Average.

πŸ“ˆ Over the past 52 weeks, COO stock fell 12.5%, contrasting with the Dow's 13.2% gain during the same period.

πŸ“‰ Technical indicators show bearish momentum as shares trade below their 200-day and 50-day moving averages.

πŸ“… On Mar. 5, COO shares dropped 2.2% after releasing mixed Q1 2026 earnings that saw revenue increase 6% to $1 billion.

πŸ’° Adjusted EPS for the quarter rose 20% year-over-year to $1.10, beating Wall Street estimates, but investors expressed concern over weak organic revenue growth and slower business in Asia Pacific.

πŸ“‰ Stock dropped another 4.6% in the subsequent trading session due to declining investor confidence following the earnings report.

βš–οΈ When compared to peer Align Technology (ALGN), which saw its stock grow 2% over the past year, COO has underperformed significantly.

πŸ† Among the 18 analysts covering the stock, the consensus rating is a "Moderate Buy" with moderately optimistic sentiment.

🎯 The mean price target of $90.81 suggests 27.8% upside potential from current price levels.

⚠️ Investors are watching closely for potential challenges in the Asia Pacific region affecting organic growth rates.

Bullish Signals
  • The company reported revenue growth of nearly 6% year-over-year, reaching $1 billion which was in line with Wall Street estimates.
  • Adjusted earnings per share (EPS) for the quarter rose 20% from the prior year's quarter to $1.10, successfully beating Wall Street estimates.
  • Analysts maintain a 'Moderate Buy' consensus rating with a mean price target of $90.81, suggesting potential upside from current levels.
Risk Factors
  • COO stock has declined 20.9% from its 52-week high of $89.83 reached on Dec. 05, 2025, indicating significant weakness despite the company's large-cap status.
  • The stock continues to underperform both the Dow Jones Industrials Average, which gained 13.2% over 52 weeks versus COO's 12.5% decline, and its peer Align Technology, Inc. (ALGN), which grew 2% over the past year.
  • COO shares are trading below its 200-day and 50-day moving averages since the start of the month, signaling sustained bearish momentum and negative technical sentiment.
  • Following its mixed Q1 2026 earnings on Mar. 5, COO stock dropped another 4.6% due to investor concerns over weak organic revenue growth and slower business in the Asia Pacific region.
  • Despite beating Wall Street estimates with adjusted EPS of $1.10 rising 20%, investors remained focused on underlying challenges in key markets that may impact long-term sustainability.
Full Analysis
The Cooper Companies, Inc. (COO), a large-cap medical device firm headquartered in California with a market capitalization of $13.9 billion, operates through two main segments: CooperVision and CooperSurgical. The company manufactures contact lens wearers, fertility products, medical devices, contraception, and cryostorage services. Despite its substantial size and industry influence, COO stock has experienced significant recent volatility, trading 20.9% below its 52-week high of $89.83 recorded on December 5, 2025. Over the past three months, the stock declined 12.3%, lagging behind the Dow Jones Industrials Average, which saw only a 2.4% decline in the same period. Looking further back over the last 52 weeks, COO shares have fallen 12.5% compared to the DOWI’s gain of 13.2%. Technical indicators and recent earnings results have contributed to this downward trend. Since the start of the current month, shares have traded below both their 200-day and 50-day moving averages, signaling bearish momentum. Following its Q1 2026 earnings release on March 5, COO shares dropped 2.2%, with a further 4.6% decline in the subsequent trading session as investor confidence waned. While the company reported revenue increases of nearly 6% year-over-year to reach $1 billion and saw adjusted earnings per share rise 20% to $1.10, beating Wall Street estimates, investors remained concerned about weak organic revenue growth and sluggish business performance in the Asia Pacific region. Comparatively, Cooper Companies has underperformed against its peer, Align Technology, Inc. (ALGN), which has grown 2% over the past year. Despite this recent decline, sentiment toward COO remains moderately optimistic with a consensus analyst rating of "Moderate Buy" among the 18 analysts covering the stock. The mean price target stands at $90.81, suggesting potential upside of approximately 27.8% from current price levels. The article concludes with a standard disclosure that Sristi Jayaswal held no positions in the securities mentioned and notes the information is for informational purposes only.